Publishing research using ab65089? Please let us know so that we can cite the reference in this datasheet.
ab65089 has been referenced in 3 publications.
Allen E et al.Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Sci Transl Med 9:N/A (2017).
Gray CM et al.Noncanonical NF-?B signaling is limited by classical NF-?B activity.Sci Signal 7:ra13 (2014).
Hehlgans T et al.Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells.Eur Cytokine Netw 14:103-7 (2003).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up